Viability testing of material derived from Mycobacterium tuberculosis prior to removal from a containment level-III laboratory as part of a Laboratory Risk Assessment Program
- PMID: 15667662
- PMCID: PMC548516
- DOI: 10.1186/1471-2334-5-4
Viability testing of material derived from Mycobacterium tuberculosis prior to removal from a containment level-III laboratory as part of a Laboratory Risk Assessment Program
Abstract
Background: In the field of clinical mycobacteriology, Mycobacterium tuberculosis (MTB) can be a difficult organism to manipulate due to the restrictive environment of a containment level 3 (CL3) laboratory. Tests for rapid diagnostic work involving smears and molecular methods do not require CL3 practices after the organism has been rendered non-viable. While it has been assumed that after organism deactivation these techniques can be performed outside of a CL3, no conclusive study has consistently confirmed that the organisms are noninfectious after the theoretical 'deactivation' steps. Previous studies have shown that initial steps (such as heating/chemical fixation) may not consistently kill MTB organisms.
Methods: An inclusive viability study (n = 226) was undertaken to determine at which point handling of culture extraction materials does not necessitate a CL3 environment. Four different laboratory protocols tested for viability included: standard DNA extractions for IS6110 fingerprinting, crude DNA preparations for PCR by boiling and mechanical lysis, protein extractions, and smear preparations. For each protocol, laboratory staff planted a proportion of the resulting material to Bactec 12B medium that was observed for growth for 8 weeks.
Results: Of the 208 isolates initially tested, 21 samples grew within the 8-week period. Sixteen (7.7%) of these yielded positive results for MTB that included samples of: deactivated culture resuspensions exposed to 80 degrees C for 20 minutes, smear preparations and protein extractions. Test procedures were consequently modified and tested again (n = 18), resulting in 0% viability.
Conclusions: This study demonstrates that it cannot be assumed that conventional practices (i.e. smear preparation) or extraction techniques render the organism non-viable. All methodologies, new and existing, should be examined by individual laboratories to validate the safe removal of material derived from MTB to the outside of a CL3 laboratory. This process is vital to establish in house biosafety-validated practices with the aim of protecting laboratory workers conducting these procedures.
Figures
Similar articles
-
Biosafety evaluation of the DNA extraction protocol for Mycobacterium tuberculosis complex species, as implemented at the Instituto Nacional de Salud, Colombia.Biomedica. 2009 Dec;29(4):561-6. Biomedica. 2009. PMID: 20440455
-
Extraction of Mycobacterium tuberculosis DNA: a question of containment.J Clin Microbiol. 2005 Jun;43(6):2996-7. doi: 10.1128/JCM.43.6.2996-2997.2005. J Clin Microbiol. 2005. PMID: 15956443 Free PMC article.
-
[Mycobacterial tests].Kekkaku. 2008 Jan;83(1):43-59. Kekkaku. 2008. PMID: 18283915 Japanese.
-
[Standardization of laboratory tests for tuberculosis and their proficiency testing].Kekkaku. 2003 Aug;78(8):541-51. Kekkaku. 2003. PMID: 14509226 Review. Japanese.
-
Biosafety in the clinical mycobacteriology laboratory.Clin Lab Med. 1996 Sep;16(3):527-50. Clin Lab Med. 1996. PMID: 8866179 Review.
Cited by
-
Biosafety and Proteome Profiles of Different Heat Inactivation Methods for Mycobacterium tuberculosis.Microbiol Spectr. 2021 Dec 22;9(3):e0071621. doi: 10.1128/spectrum.00716-21. Epub 2021 Dec 22. Microbiol Spectr. 2021. PMID: 34937194 Free PMC article.
-
Heat Inactivation Renders Sputum Safe and Preserves Mycobacterium tuberculosis RNA for Downstream Molecular Tests.J Clin Microbiol. 2019 Mar 28;57(4):e01778-18. doi: 10.1128/JCM.01778-18. Print 2019 Apr. J Clin Microbiol. 2019. PMID: 30728191 Free PMC article.
-
Pilot study of a rapid and minimally instrumented sputum sample preparation method for molecular diagnosis of tuberculosis.Sci Rep. 2016 Jan 20;6:19541. doi: 10.1038/srep19541. Sci Rep. 2016. PMID: 26785769 Free PMC article.
-
Mycobacterium senegalense tissue infection in a child after fish tank exposure.Can J Infect Dis Med Microbiol. 2011 Fall;22(3):101-3. doi: 10.1155/2011/206532. Can J Infect Dis Med Microbiol. 2011. PMID: 22942887 Free PMC article.
-
Dried culture spots for Xpert MTB/RIF external quality assessment: results of a phase 1 pilot study in South Africa.J Clin Microbiol. 2011 Dec;49(12):4356-60. doi: 10.1128/JCM.05167-11. Epub 2011 Oct 5. J Clin Microbiol. 2011. PMID: 21976767 Free PMC article.
References
-
- Collins CH, Kennedy DA. Laboratory-acquired Infections: History, Incidence, Causes and Prevention. 4th. U. K., Butterworth Heinemann; 1998.
-
- Miller CD, Songer JR, Sullivan JF. A twenty-five year review of laboratory-acquired human infections at the National Animal Disease Center. Am Ind Hyg Assoc J. 1987;48:271–275. - PubMed
-
- Pike RM. Laboratory-associated infections: summary and analysis of 3921 cases. Health Lab Sci. 1976;13:105–114. - PubMed
-
- Garber E, San Gabriel P, Lambert L, Saiman L. A survey of latent tuberculosis infection among laboratory healthcare workers in New York City. Infect Control Hosp Epidemiol. 2003;24:801–806. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical